BioPlus Acquisition Corp.
BIOS · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $6,109,434 | $67 | $1,253,420 | $1,213,240 |
| - Cash | $140 | $636 | $14,500 | $39,500 |
| + Debt | $5,000 | $5,000 | $504,700 | $480,600 |
| Enterprise Value | $6,114,294 | $4,432 | $1,743,620 | $1,654,340 |
| Revenue | $0 | $0 | $708,900 | $817,200 |
| % Growth | – | -100% | -13.3% | – |
| Gross Profit | -$1,171 | $0 | $243,000 | $269,300 |
| % Margin | – | – | 34.3% | 33% |
| EBITDA | -$1,171 | $0 | -$84,900 | -$24,970 |
| % Margin | – | – | -12% | -3.1% |
| Net Income | $5,163 | -$0 | -$51,600 | -$131,000 |
| % Margin | – | – | -7.3% | -16% |
| EPS Diluted | 0.2 | -0.022 | -0.4 | -1.06 |
| % Growth | 1,000.9% | 94.5% | 62.3% | – |
| Operating Cash Flow | -$691 | -$1 | -$20,100 | -$760 |
| Capital Expenditures | $0 | $0 | -$13,880 | -$8,680 |
| Free Cash Flow | -$691 | -$1 | -$33,980 | -$9,440 |